{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {"h" : "Thanksgiving Day"}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
businesswire

American Vanguard Reports Third Quarter & Nine Month 2009 Results


  • Press Release
  • Source: American Vanguard Corporation
  • On 9:00 am EST, Wednesday November 4, 2009

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE:AVD - News), today announced financial results for the three and nine month periods ended September 30, 2009.

Related Quotes

SymbolPriceChange
AVD7.17+0.02
Chart for AMER VANGUARD CP
{"s" : "avd","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Fiscal 2009 Third Quarter Financial Highlights – versus Fiscal 2008 Third Quarter:

  • Net sales were $66.4 million compared to $67.6 million.
  • Net income was $2.1 million compared to $6.0 million.
  • Earnings per diluted share were $0.08 versus $0.22.

Fiscal 2009 Nine Month Financial Highlights – versus Fiscal 2008 Nine Month Results:

  • Net sales were $158.5 million compared to $166.5 million.
  • Net income was $2.8 million compared to $12.1 million.
  • Earnings per diluted share were $0.10 versus $0.44.

Eric Wintemute, President and CEO of American Vanguard, stated: “Amidst challenging conditions in the Ag Chemical marketplace presently, we delivered quarterly sales revenues roughly equal to the same period last year. While some of our product portfolio outperformed the prior year period, we were negatively impacted by diminished sales of two very important seasonal contributors. Reduced demand for our Dibrom® mosquito adulticide resulted from less hurricane related precipitation in the Gulf Coast region. Relative to a very strong season in 2008, sales of this highly profitable mosquito eradicator were off by about 70% this year. Additionally, quarterly global sales of our leading fungicide product were about 35% below the prior year, as a result of reduced demand in international markets.

“As we previously reported, we have reacted to recent softness in domestic market demand by scaling back the production output of our manufacturing facilities in order to refrain from building excess inventories. Running factories at reduced operating rates has made it necessary to expense unabsorbed overheads resulting in lower gross profit margins. Indeed, the combination of lower sales of high margin products like Dibrom and the expensing of unabsorbed manufacturing costs has resulted in diminished profitability in the current quarter.”

Mr. Wintemute continued: “We have made significant progress toward the balance sheet objectives that we established in our last quarterly report to shareholders. During the current quarter, we reduced inventory levels by over 10%, maintained our diligence in receivables collection and generated sufficient cash to reduce the outstanding balance on our revolving credit line by over 35%.”

Mr. Wintemute concluded, “Our organization is focusing its full attention on improving our operating performance, achieving better financial results and strengthening our corporate balance sheet.”

Conference Call

Eric Wintemute, President & CEO, Trevor Thorley, EVP & COO and David T. Johnson, CFO, will conduct a conference call focusing on the financial results at 12:00 pm ET / 9:00 am PT on Wednesday, November 4, 2009. Interested parties may participate in the call by dialing 706-679-3155 – please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call (conference ID # 33510653). The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands except per share amounts)
(Unaudited)
       
For the three months For the nine months
ended September 30 ended September 30
2009 2008 2009 2008
Net sales $ 66,371 $ 67,636 $ 158,493 $ 166,478
Cost of sales   45,007     38,850     102,154     96,344  
 
Gross profit 21,364 28,786 56,339 70,134
Operating expenses   17,470     18,111     49,570     47,493  
 
Operating income 3,894 10,675 6,769 22,641
Interest expense 825 1,098 2,622 3,345
Interest income (75 )
Interest capitalized   (12 )   (63 )   (38 )   (171 )
 
Income before income taxes 3,081 9,640 4,185 19,542
Income tax expense   984     3,611     1,393     7,438  
 
Net income $ 2,097   $ 6,029   $ 2,792   $ 12,104  
 
Earnings per common share—basic $ .08   $ .23   $ .10   $ .46  
 
Earnings per common share—assuming dilution $ .08   $ .22   $ .10   $ .44  
 
Weighted average shares outstanding—basic   27,124     26,788     27,071     26,596  
 
Weighted average shares outstanding—assuming dilution   27,609     27,580     27,660     27,500  
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands)
ASSETS
   
September 30, Dec. 31,
2009 2008
(Unaudited) (Note)
Current assets:
Cash and cash equivalents $ 901 $ 1,229
Receivables:
Trade, net of allowance for doubtful accounts of $330 and $472 56,355 51,405
Other   328     563  
 
  56,683     51,968  

 

Inventories 99,475 90,626
Prepaid expenses   1,568     1,688  
 
Total current assets 158,627 145,511
Property, plant and equipment, net 40,247 41,241
Intangible assets 88,083 91,079
Other assets   9,443     9,106  
 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 
$ 296,400   $ 286,937  
 
 
September 30, Dec. 31,
2009 2008
(Unaudited) (Note)
Current liabilities:
Current installments of long-term debt $ 9,506 $ 6,656
Accounts payable 17,390 16,196
Accrued program costs 24,989 16,204
Accrued expenses and other payables 5,283 6,767
Income taxes payable   954     3,332  
 
Total current liabilities 58,122 49,155
Long-term debt, excluding current installments 72,268 75,748
Deferred income taxes   6,021     6,091  
 
Total liabilities   136,411     130,994  
 
Commitments and contingent liabilities
Stockholders’ Equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 29,412,015 shares at September 30, 2009 and 29,209,863 shares at December 31, 2008

2,941 2,920
Additional paid-in capital 40,215 38,873
Accumulated other comprehensive loss

(2,091

)

(3,593 )
Retained earnings   122,077     120,896  
 
163,142 159,096

Less treasury stock, at cost, 2,260,996 shares at September 30, 2009 and December 31, 2008

 

(3,153

)

 

(3,153

)

 
Total stockholders’ equity   159,989     155,943  
 
$ 296,400   $ 286,937  

Note: The balance sheet at December 31, 2008 has been derived from the audited financial statements at that date.

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
For The Nine Months Ended September 30, 2009 and 2008
(Unaudited)
   

Increase (decrease) in cash

2009 2008
Cash flows from operating activities:
Net income $ 2,792 $ 12,104
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 10,124 8,711
Deferred income tax (70 ) 774

Stock-based compensation expense related to stock options and employee stock purchases

895 554
Changes in assets and liabilities associated with operations:
Increase in receivables (4,715 ) (10,461 )
Increase in inventories (8,849 ) (25,792 )
Increase in prepaid expenses and other assets (2,281 ) (1,702 )
Increase in accounts payable 2,351 4,317
Increase in other current liabilities   4,103     9,303  
 
Net cash provided (used in) operating activities   4,350     (2,192 )
 
Cash flows from investing activities:
Capital expenditures (3,746 ) (8,101 )
Acquisitions of intangible assets       (8,892 )
 
Net cash used in investing activities   (3,746 )   (16,993 )
 
Cash flows from financing activities:
Net borrowings under line of credit agreement 3,000 23,000
Principal payments on long-term debt (3,080 ) (3,080 )
Proceeds from the issuance of common stock from exercise of stock options and sale of stock under ESPP 468 1,329
Acquisition of Treasury stock (408 )
Payment of cash dividends   (1,341 )   (1,323 )
 
Net cash (used in) provided by financing activities   (953 )   19,518  
 
Net (decrease) increase in cash (349 ) 333
Cash and cash equivalents at beginning of period 1,229 3,201
Effect of exchange rate changes on cash   21     (380 )
 
Cash and cash equivalents as of September 30, $ 901   $ 3,154  

Contact:

American Vanguard Corporation
William A. Kuser, 949-260-1200
Director of Investor Relations
williamk@amvac-chemical.com
or
Investor Representative
The Equity Group Inc.
Lena Cati, 212-836-9611
Lcati@equityny.com
www.theequitygroup.com

Sponsored Links

Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.